HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Silingardi Selected Research

Serpins

5/2000Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Silingardi Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
09/2002 - 05/2000
2Lymphoma (Lymphomas)
11/2000 - 03/2000
1Varicocele
08/2005
1Carcinoma (Carcinomatosis)
09/2002
1Disease Progression
05/2000
1Circulating Neoplastic Cells
05/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2000
1Myocardial Infarction
03/2000
1Neoplasms (Cancer)
02/2000
1Diarrhea
01/2000
1Colorectal Neoplasms (Colorectal Cancer)
01/2000

Drug/Important Bio-Agent (IBA)

1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2005
1Dacarbazine (DIC)FDA LinkGeneric
09/2002
1Nonsense Codon (Nonsense Mutation)IBA
09/2002
1PlasticsIBA
11/2000
1ImmunosorbentsIBA
11/2000
1EnzymesIBA
11/2000
1Protease Inhibitors (Protease Inhibitor)IBA
05/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2000
1Messenger RNA (mRNA)IBA
05/2000
1SERPIN-B5 (maspin)IBA
05/2000
1SerpinsIBA
05/2000
1Proteins (Proteins, Gene)FDA Link
05/2000
1Pharmaceutical PreparationsIBA
03/2000
1Progesterone Receptors (Progesterone Receptor)IBA
02/2000
1Estrogens (Estrogen)FDA Link
02/2000
1Loperamide (Imodium)FDA LinkGeneric
01/2000
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2000
1Octreotide (Sandostatin)FDA LinkGeneric
01/2000

Therapy/Procedure

4Drug Therapy (Chemotherapy)
11/2000 - 01/2000
2Therapeutics
05/2000 - 03/2000
1PROMACE-CytaBOM protocol
03/2000